Consumer Goods & Retail Global On demand · 24-48h

Global Cosmetic Grade Dipotassium Glycyrrhizinate Market Strategic Research Report

Global Cosmetic Grade Dipotassium Glycyrrhizinate Market Str…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Cosmetic Grade Dipotassium Glycyrrhizinate Market
$35.182025
7.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Purity ≥99%, Purity <99%

By Application: Beauty Products, Skin Care Product, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: GfN Selco, Xinjiang Tianshan Pharmaceutical, Nikko Chemicals, Fanzhi Pharmaceutical, MAFCO Worldwide, Shaanxi Jintai Biological Engineering, Jiangsu Tiansheng Pharmaceutical, Qinghai Lake Pharmaceutical, VITAL-CHEM Zhuhai, Shaanxi Fujie Pharmaceutical, Qingdao Taitong Pharmaceutical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 123 pages
Market size 2025
$35.18
Million USD
Forecast CAGR
7.4%
2025-2032
Forecast 2032
$58
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Cosmetic Grade Dipotassium Glycyrrhizinate market size is predicted to grow from US$ 35.18 million in 2025 to US$ 57.59 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Dipotassium Glycyrrhizinate (DPG) is a water-soluble salt derived from glycyrrhizic acid, a natural compound extracted from licorice root (Glycyrrhiza glabra). It is widely used in cosmetic, pharmaceutical, and personal care applications due to its anti-inflammatory, anti-allergic, anti-irritant, and skin-soothing properties. Chemically stable and non-toxic, DPG is particularly effective at modulating inflammatory responses and reducing redness or irritation, making it ideal for sensitive skin formulations.

In cosmetics and skincare, it is commonly found in products like facial cleansers, sunscreens, serums, creams, and masks, especially those targeting eczema, acne, and rosacea. In pharmaceuticals and oral care, it is used in topical corticosteroids, throat lozenges, and toothpaste for its soothing and anti-ulcer activity. DPG is often preferred over raw licorice extracts due to its standardized composition, enhanced water solubility, and higher safety profile.

The Dipotassium Glycyrrhizinate market is growing steadily, driven by consumer demand for natural, anti-inflammatory ingredients in skincare, oral care, and pharmaceuticals. Its ability to address redness, irritation, and allergic reactions makes it indispensable in modern formulations, especially as global consumers shift toward milder, more plant-based products. While challenges related to raw material supply persist, the market is likely to expand further as DPG finds new applications in clean beauty, therapeutic skincare, and wellness-driven product lines.

The growth of the “sensitive skin” and “clean beauty” movements has significantly increased the demand for gentle, plant-derived actives like dipotassium glycyrrhizinate. Consumers increasingly seek products that avoid harsh chemicals and instead use natural, dermatologically safe ingredients. DPG’s ability to reduce inflammation, inhibit histamine release, and calm irritation positions it as a go-to functional ingredient in both premium and mass-market skincare lines worldwide.

With growing awareness around sun protection and skin barrier health, DPG is being used more frequently in sun care products for its ability to counteract UV-induced irritation and erythema. Additionally, it's gaining traction in post-laser and post-peel skincare for its calming effects on damaged or inflamed skin. The rise in cosmetic dermatology treatments is creating demand for adjunct ingredients like DPG that can accelerate skin recovery and improve user comfort.

Asian markets, especially Japan, South Korea, and China, have long embraced licorice-based ingredients due to traditional herbal medicine roots. DPG continues to see widespread use in herbal and cosmeceutical products in these regions. In China, it is frequently used in whitening, acne control, and TCM-inspired personal care products. As K-beauty and J-beauty influence spreads globally, DPG is also finding new markets in Europe and North America.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cosmetic Grade Dipotassium Glycyrrhizinate market?

What factors are driving Cosmetic Grade Dipotassium Glycyrrhizinate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cosmetic Grade Dipotassium Glycyrrhizinate market opportunities vary by end market size?

How does Cosmetic Grade Dipotassium Glycyrrhizinate break out by Type, by Application?

This report presents a comprehensive overview of the global Cosmetic Grade Dipotassium Glycyrrhizinate market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Purity ≥99%
  • Purity <99%

Segment by Application

  • Beauty Products
  • Skin Care Product
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cosmetic Grade Dipotassium Glycyrrhizinate market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Beauty Products, Skin Care Product, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Cosmetic Grade Dipotassium Glycyrrhizinate Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$35.18
2025
Forecast
$58
2032
CAGR
7.4%
2025–2032
Regiones
5
global
Key companies
GfN SelcoXinjiang Tianshan PharmaceuticalNikko ChemicalsFanzhi PharmaceuticalMAFCO WorldwideShaanxi Jintai Biological EngineeringJiangsu Tiansheng PharmaceuticalQinghai Lake Pharmaceutical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Purity ≥99%Purity <99%
By Application
Beauty ProductsSkin Care ProductOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Purity ≥99%
  • 3.1.3 Purity <99%
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Beauty Products
  • 4.1.3 Skin Care Product
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 GfN Selco
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Xinjiang Tianshan Pharmaceutical
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nikko Chemicals
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Fanzhi Pharmaceutical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 MAFCO Worldwide
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shaanxi Jintai Biological Engineering
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Jiangsu Tiansheng Pharmaceutical
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Qinghai Lake Pharmaceutical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 VITAL-CHEM Zhuhai
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Shaanxi Fujie Pharmaceutical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Qingdao Taitong Pharmaceutical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Cosmetic Grade Dipotassium Glycyrrhizinate market?
The global Cosmetic Grade Dipotassium Glycyrrhizinate market is estimated at US$ 35.18 million in 2025 (base year) and is projected to reach US$ 57.59 million by 2032.
How fast is the Cosmetic Grade Dipotassium Glycyrrhizinate market expected to grow?
The market is expected to grow at a CAGR of 7.4% from 2026 to 2032, expanding from US$ 35.18 million in 2025 to US$ 57.59 million in 2032, roughly 1.6 times its base-year value.
What does the Cosmetic Grade Dipotassium Glycyrrhizinate market cover?
Dipotassium Glycyrrhizinate (DPG) is a water-soluble salt derived from glycyrrhizic acid, a natural compound extracted from licorice root (Glycyrrhiza glabra). It is widely used in cosmetic, pharmaceutical, and personal care applications due to its anti-inflammatory, anti-allergic, anti-irritant, and skin-soothing properties. Chemically stable and non-toxic, DPG is particularly effective at modulating inflammatory responses and reducing redness or irritation, making it ideal for sensitive skin formulations.
What are the main segments of the Cosmetic Grade Dipotassium Glycyrrhizinate market by type?
By type, the market is segmented into Purity ≥99% and Purity <99%.
Which applications drive demand in the Cosmetic Grade Dipotassium Glycyrrhizinate market?
Key applications covered include Beauty Products, Skin Care Product and Others.
Who are the key players in the Cosmetic Grade Dipotassium Glycyrrhizinate market?
Key players profiled include GfN Selco, Xinjiang Tianshan Pharmaceutical, Nikko Chemicals, Fanzhi Pharmaceutical, MAFCO Worldwide, Shaanxi Jintai Biological Engineering, Jiangsu Tiansheng Pharmaceutical and Qinghai Lake Pharmaceutical, among 11 companies covered in total.
Which regions and countries are covered for Cosmetic Grade Dipotassium Glycyrrhizinate?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Cosmetic Grade Dipotassium Glycyrrhizinate market?
The Dipotassium Glycyrrhizinate market is growing steadily, driven by consumer demand for natural, anti-inflammatory ingredients in skincare, oral care, and pharmaceuticals.
What challenges does the Cosmetic Grade Dipotassium Glycyrrhizinate market face?
While challenges related to raw material supply persist, the market is likely to expand further as DPG finds new applications in clean beauty, therapeutic skincare, and wellness-driven product lines.
Who should buy the Cosmetic Grade Dipotassium Glycyrrhizinate market report?
The report is intended for manufacturers and solution providers, distributors and end users in Beauty Products, Skin Care Product and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cosmetic Grade Dipotassium Glycyrrhizinate market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.